Health
Health News
Chubb to Acquire Cigna’s $3 Billion Premium Revenue Personal Accident, Supplemental Health and Life Insurance Business in Seven Asia-Pacific Markets for $5.75 Billion
Chubb to Acquire Cigna's $3 Billion Premium Revenue Personal Accident, Supplemental Health and Life Insurance Business in Seven Asia-Pacific Markets...
Read moreCigna Reaches Agreement With Chubb To Divest Its Life, Accident And Supplemental Benefits Businesses In Seven Countries
Cigna Reaches Agreement With Chubb To Divest Its Life, Accident And Supplemental Benefits Businesses In Seven Countries Agreement will sharpen...
Read moreChubb to Acquire Cigna’s $3 Billion Premium Revenue Personal Accident, Supplemental Health and Life Insurance Business in Seven Asia-Pacific Markets for $5.75 Billion
Chubb to Acquire Cigna's $3 Billion Premium Revenue Personal Accident, Supplemental Health and Life Insurance Business in Seven Asia-Pacific Markets...
Read moreCigna Reaches Agreement With Chubb To Divest Its Life, Accident And Supplemental Benefits Businesses In Seven Countries
Cigna Reaches Agreement With Chubb To Divest Its Life, Accident And Supplemental Benefits Businesses In Seven Countries PR Newswire BLOOMFIELD,...
Read moreCigna Reaches Agreement With Chubb To Divest Its Life, Accident And Supplemental Benefits Businesses In Seven Countries
Cigna Reaches Agreement With Chubb To Divest Its Life, Accident And Supplemental Benefits Businesses In Seven Countries PR Newswire BLOOMFIELD,...
Read moreCigna Reaches Agreement With Chubb To Divest Its Life, Accident And Supplemental Benefits Businesses In Seven Countries
Cigna Reaches Agreement With Chubb To Divest Its Life, Accident And Supplemental Benefits Businesses In Seven Countries Agreement will sharpen...
Read moreCStone presents research data of CS5001 (ROR1 ADC) at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021
CStone presents research data of CS5001 (ROR1 ADC) at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics...
Read moreIsoPlexis Announces Pricing of Initial Public Offering
IsoPlexis Announces Pricing of Initial Public Offering PR Newswire BRANFORD, Conn., Oct. 7, 2021 BRANFORD, Conn., Oct. 7, 2021 /PRNewswire/...
Read moreMirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS G12C-mutated Lung Cancer
Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS...
Read moreHealthcare Trust of America, Inc. Announces $1.3 Billion Revolving Credit and Term Loan Agreement
Healthcare Trust of America, Inc. Announces $1.3 Billion Revolving Credit and Term Loan Agreement PR Newswire SCOTTSDALE, Ariz., Oct. 7,...
Read more